Rheumatology Advance Access published online on May 5, 2006
Rheumatology, doi:10.1093/rheumatology/kel135
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Rheumatology Clinic, DPMSC, University of Udine, Italy
* To whom correspondence should be addressed.
Accepted March 22, 2006
Letter to the Editor (Matters Arising)
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia
Salvatore De Vita 1 *
and
Luca Quartuccio 1
Salvatore De Vita, E-mail: salvatore.devita{at}med.uniud.it
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Quartuccio, M. Fabris, S. Salvin, M. Isola, F. Soldano, E. Falleti, C. A. Beltrami, V. De Re, and S. De Vita Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis Rheumatology, November 1, 2007; 46(11): 1657 - 1661. [Abstract] [Full Text] [PDF] |
||||
